UC Breast Cancer Researcher Earns Prestigious Leadership Fellowship
Hanging on the door of Dr. Mary Mahoneys office is a poster of the brain with the words, Youre a radiologist in the making.
The University of Cincinnati breast cancer expert and researcher, known for inspiring others to research excellence, will now join the ranks of influential medical leaders as a part-time fellow at the International Center for Executive Leadership in Academics.
Mahoney, interim chair of the University of Cincinnati Department of Radiology and professor in the College of Medicine, was selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program in April.
The program is a highly selective, year-long, part-time fellowship for women faculty in schools of medicine, dentistry and public health, according to ELAM. More than 800 ELAM alumnae hold leadership positions in institutions around the world.
Mahoneys medical work is guided by a simple yet powerful mantra: Todays research is tomorrows practice. Her work focuses on the earlier and more precise detection of breast cancer.
I would love to get to the point where we can completely eradicate [breast cancer], Mahoney said. If we can find it earlier, the treatment is less invasive and the outcomes can be much better.
Breast cancer remains one of the most common cancers among women. In 2015, an estimated 231,840 new cases of invasive breast cancer in women will be diagnosed, and 40,290 breast cancer deaths will occur, according to the Susan G. Komen Foundation.
Mahoney researches mechanisms and screening protocols that cab detect cancer at its earliest stages. Through 3-D digital breast imaging and spectroscopy, radiologists are able to look at the breast tissue layer by layer to detect and treat cancer not only earlier, but more effectively because of its more targeted approach. Her research includes a digital mammography imaging screening trial, a MRI breast cancer trial and high-risk breast cancer ultrasound screening.
Were tailoring treatment to patients; knowing that for chemotherapy, not one size fits all, Mahoney said. It doesnt fit every tumor, and not every screening fits every patient.
The Department of Radiology at UC performs around 350,000 imaging exams annually and houses 30 residents and nine fellows.
Radiology tends to occur in closed-off rooms, studying images and conferring with physicians but not patients, she said. Mahoney cherishes the moments she spends interacting the people she treats. With breast imaging, Mahoney is able to do all the biopsies, the work-ups and talk to patients about their results.
Women in particular are wonderful patients. Theyre obviously anxious and I definitely get those moments where theres tears, she said. There is sadness, but theres a huge amount of hugs and relief, too. Its just amazing the kind of strength women have.
Mahoneys passion for research and her insatiable intellectual curiosity have kept her interested and motivated in the field of radiology. While females in academia and medicine are still not the norm.
Mahoney received her undergraduate degree from Brown University, graduating summa cum laude. She completed medical school, her residency and her fellowship at UC. She encourages women to pursue a career in medicine.
Im a huge fan of smart, powerful women. I want them to go for it. We need more women in medicine with passion and compassion, Mahoney said. Its hard. There are huge sacrifices to make. Its a long haul but the rewards at the end are great.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Designing with cancer patients' needs in focus
August 27, 2026
Kristina Shin is designing garments that prioritize the comfort, function and confidence of breast cancer patients, addressing a need often overlooked by traditional fashion.